Great teams have great bullpens. Add Melbourne to yours.
- Access Australia’s high-quality, cost-competitive, rapid start-up clinical trials ecosystem.
- Elevate your portfolio with access to Australia’s breakthrough biotech pipeline.
- Scale successfully from Australia: trusted, talent-rich and globally connected.
Looking to accelerate development and extend your runway?
For high-leverage reliability, Melbourne’s clinical trial service providers are your gateway to Australia’s high-quality, cost-competitive, rapid start-up clinical trials ecosystem.
- Achieve maximum impact for your investment.
- High-quality data accepted by global regulators including the FDA and EMA.
- Fast and pragmatic regulatory environment that delivers early-phase ethics approval and study initiation within weeks.
- Cost-competitive pricing plus up to 43.5% cash refund on eligible R&D expenditure (from discovery stage R&D to clinical trials).
- Australia's premier clinical trial destination with seamless connectivity to national networks.
- 60% of 2024 FDA approvals included clinical trial sites in Victoria 1.
- 90% of Victorian Phase I clinical trials sponsored by international firms 2.
- ¼ of all clinical trials in Australia conducted in Victoria 3.
- 35% of Australia’s Phase I trial facility beds located in Victoria 4.
- Outstanding capability across First-in-Human > Phase IV trials.
- National Mutual Acceptance Scheme allows for single ethics approval for multi-site trials across state borders.
- Home to GMP-licensed API, FDF, and Fill & Finish manufacturers.
1. Novel Drug Approvals for 2024: FDA and GlobalData Pharma Intelligence Center | 2. All Australian clinical trials 2025, GlobalData Pharma Intelligence Center | 3. All Australian clinical trials 2025, GlobalData Pharma Intelligence Center. | 4. All Australian clinical trials 2025, GlobalData Pharma Intelligence Center.
Looking to discover your next high-value healthtech asset?
An elite showcase of discovery and innovation, Melbourne is the ideal place to scout groundbreaking medtech and first-in-class biotech assets.
- Tap into a world-renowned discovery engine.
- One of only 3 countries to feature multiple cities in Nature’s top 25 leading science cities index for health sciences.
- Exceptional research quality and innovative, defensible IP.
- High-value opportunities across medtech, small molecules, advanced biologics and targeted therapies.
- Opportunities across high-impact therapeutic areas including immunology, cardiology, neurology, oncology, and rare diseases.
- Melbourne, Australia’s health and life sciences capital.
- Home to Australia’s best research institutions including top-ranked university, top-ranked MRI and top-ranked hospital 5.
- 60+ healthtech startups founded annually 6.
- Melbourne’s innovation hubs, including the Melbourne Biomedical Precinct (Parkville) and Monash Technology Precinct, create centralised opportunity marketplaces.
5. Nature Index 2026 Institution Rankings. https://www.nature.com/nature-index/institution-outputs/generate/health-sciences/countries-Australia/all | 6. Victorian-Startup-Growth-Report-2025_Final.pdf
Looking to scale globally?
Secure a decisive home-field advantage in APAC, when you make Melbourne your home-away-from-home.
- Scale with confidence.
- Highly skilled workforce with specialist expertise spanning R&D and advanced manufacturing including cutting edge modalities.
- Highly ranked intellectual property system with notable strengths across patents, commercialisation of IP assets, system efficiency, and alignment with international standards.
- World-leading universal healthcare system delivering high patient access rate to medicines and single-buyer market simplicity.
- Established trading relationships within APAC and other global markets.
- Enduring Australian and Victorian State Government backing as a designated priority sector.
- Australia’s largest healthtech ecosystem, built for global impact.
- 43% of Australian ASX-listed healthtech firms based in Melbourne 7.
- 60% of Australia’s pharmaceutical product exported from Melbourne 8.
- Home to Australia’s premier biomedical precincts integrating the leading healthtech firms, infrastructure, research, education, and clinical institutions to accelerate partnerships and knowledge sharing.
- Strong talent pipeline with 2 universities in the global top 30 for life sciences and medicine, and 24,000 health and life science graduates annually.
- Access 80% of Australia’s population within 24 hours by road and rail networks. Access the rest of the world by Australia’s largest, best-connected and most productive container port, and Australia’s busiest airport.
Doing Business Globally
We can help you do business with the U.S., Canada, and Melbourne supported by Victoria’s global trade and investment network.
About Global Victoria
At Global Victoria, we can connect you with Australia’s leading clinical trial service providers and skilled contract development and manufacturing partners that are experts in supporting innovators from around the world to access the Australian advantage to accelerate product development.
We can also connect you with the Australian innovators who are driving the development of cutting-edge medtech and biotech assets.
And, we can help you amplify your commercial potential in international markets. Specialists in our global network of 23 Victorian Government Trade and Investment offices:
- provide insight and market intelligence
- facilitate connections to buyers, partners and business leaders
- help you to understand market regulations and requirements
- work with you to build your skills and knowledge about key export opportunities
About Invest Victoria
At Invest Victoria, we can help you do business with Melbourne and support your market entry or expansion into Victoria.
Our in-market investment team can connect you with the Melbourne healthtech ecosystem to:
- access networks of the right highly skilled talent
- identify potential clients, partners, and suppliers
- establish the right partnerships
- access research infrastructure
- identify suitable business locations
- access assistance from all levels of government.
Visit the Invest Victoria website to learn more about how we can support you.
Connect with us
Our US office
Ines Benabida
Investment and Trade Director
Biotechnology, Life Sciences, Medical R&D and Technology
Email: ines.benabida@global.vic.gov.au
Sofia O'Hara
Trade Manager
Health and Life Sciences
Email: sofia.ohara@global.vic.gov.au
Our Melbourne office
Libby Kruse
Senior Trade Manager
Health and Life Sciences